Ehsan Rezaie
Overview
Explore the profile of Ehsan Rezaie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghasemi D, Araeynejad F, Maghsoud O, Gerami N, Keihan A, Rezaie E, et al.
Iran J Sci Technol Trans A Sci
. 2022 Dec;
46(6):1555-1562.
PMID: 36466050
Supplementary Information: The online version contains supplementary material available at 10.1007/s40995-022-01382-7.
2.
Ataee M, Mirhosseini S, Mirnejad R, Rezaie E, Mahmoodzadeh Hosseini H, Amani J
Res Pharm Sci
. 2022 Aug;
17(4):428-444.
PMID: 36034078
Background And Purpose: The lack of a new effective treatment for small cell lung cancer (SCLC) is an unresolved problem. Due to the new identification of delta-like ligand 3 (DLL3)...
3.
Akbarian M, Rezaie E, Farjadian F, Bazyar Z, Hosseini-Sarvari M, Ara E, et al.
RSC Adv
. 2022 May;
10(63):38260-38274.
PMID: 35517555
Looking through a historical lens, attention to the stabilization of pharmaceutical proteins/peptides has been dramatically increased. Human insulin is the most challenging and the most widely used pharmaceutical protein in...
4.
Hashemi Yeganeh H, Heiat M, Kieliszek M, Alavian S, Rezaie E
Toxins (Basel)
. 2021 Nov;
13(11).
PMID: 34822533
Hepatocellular carcinoma (HCC) is one of the high-metastatic types of cancer, and metastasis occurs in one-third of patients with HCC. To maintain the effectiveness of drug compounds on cancer cells...
5.
Heiat M, Hashemi Yeganeh H, Alavian S, Rezaie E
Toxins (Basel)
. 2021 Oct;
13(10).
PMID: 34679012
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Therefore, fighting against such cancer is reasonable. Chemotherapy drugs are sometimes inefficient and often accompanied by undesirable...
6.
Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, et al.
Arch Med Res
. 2021 Jul;
53(1):79-85.
PMID: 34229896
Background: Melatonin has been known as an anti-inflammatory agent and immune modulator that may address progressive pathophysiology of coronavirus disease 2019 (COVID-19). Aim Of The Study: To evaluate the clinical...
7.
Sohrabi E, Moslemi M, Rezaie E, Nafissi N, Khaledi M, Afkhami H, et al.
Genes Genomics
. 2021 Jun;
43(9):1065-1077.
PMID: 34097251
Background: Breast cancer (BC) is a common malignancy with a high mortality rate. Malignant cell transformation is associated with metabolic changes. One group of proteins that are affected is the...
8.
Sohrabi E, Rezaie E, Heiat M, Sefidi-Heris Y
Biochem Genet
. 2021 Apr;
59(5):1326-1358.
PMID: 33813720
Although many genes and miRNAs have been reported for various cancers, pancreatic cancer's specific genes or miRNAs have not been studied precisely yet. Therefore, we have analyzed the gene and...
9.
Keshtvarz M, Salimian J, Amani J, Douraghi M, Rezaie E
In Silico Pharmacol
. 2021 Mar;
9(1):19.
PMID: 33643767
Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-021-00079-w.
10.
Mohammadi M, Rezaie E, Sakhteman A, Zarei N
J Biomol Struct Dyn
. 2020 Oct;
40(6):2546-2556.
PMID: 33118476
Chemokines are the large family of chemotactic cytokines that play an important role in leukocyte movement and migration stimulation. Until now, several antibody-cytokine (chemokine) fusion proteins have been investigated in...